|会社名||Merit Medical Systems Inc. （メリット・メディカル・システムズ）|
|分野（sector）||Health Care ヘルスケア|
|業種||医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care）|
|概要||事業概要 メリット・メディカル・システムズ（Merit Medical Systems Inc.）は各種の介入・診断・治療手順用使い捨て医療機器の製造・販売を行う。同社は心臓血管事業と内視鏡検査事業の2つの事業を運営する。心臓血管事業は冠状動脈疾病、末梢血管疾病及び他の非血管性疾病の診断・治療を支持する心臓学と放射線装置、並びに塞栓治療、心臓リズム管理（CRM）、電気生理学（EP）および介入腫瘍治療および スパインデバイスを含む。内視鏡検査事業は悪性腫瘍に原因する食道の拡大、気管と気管支・胆汁狭窄の緩和治療を支持する胃腸病学と肺臓学医療装置を提供する。同社は末梢介入、心臓介入、介入腫瘍学と脊柱、内視鏡検査という4つの製品グループに焦点を当てた製品を提供する。 メリット・メディカル・システムズは、米国の医療機器製造業者。診断で使用する医療機器の開発、製造、販売を行う。心臓病・放射線学分野にて冠動脈疾患、末梢血管疾患の診断と治療に塞栓術療法の製品を提供。また消化器・呼吸器分野にて悪性腫瘍に起因する食道・気管気管支・胆道狭窄の拡大の緩和治療に使う内視鏡などの医療機器を手掛ける。 Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.|
|本社所在地||1600 West Merit Parkway South Jordan UT 84095 USA|
|代表者氏名||Fred P. Lampropoulos フレッドP.ランポロプロス|
|代表者役職名||Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO）|
|市場名||NASDAQ National Market System|
|決算概要||決算概要 BRIEF: For the six months ended 30 June 2018 Merit Medical Systems Inc. revenues increased 20% to $427.8M. Net income decreased 33% to $16.2M. Revenues reflect Cardiovascular segment increase of 20% to $412.2M Endoscopy segment increase of 19% to $15.6M. Basic Earnings per Share excluding Extraordinary Items decreased from $0.52 to $0.32.|
Bone Tumor Ablation Devices Market See Incredible Growth 2022-2028 | Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc 2022/06/20 13:40:31 OpenPR
Coherent Market Insights has released a new research study on the "Bone Tumor Ablation Devices Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Bone Tumor Ablation Devices Market Report
Merit Medical Systems, Inc. Shares Close in on 52-Week Low - Market Mover 2022/06/17 00:00:00 Kwhen Finance
Merit Medical Systems, Inc. (MMSI) shares closed today at 1.3% above its 52 week low of $51.31, giving the company a market cap of $2B. The stock is currently down 16.5% year-to-date, down 15.8% over the past 12 months, and up 47.1% over the past five years. This week, the Dow Jones Industrial Average fell 4.8%, and the S&P 500 fell 5.7%. Trading Activity Trading volume this week was 10.4% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 1.3% lower than its 5-day moving average, 11.1% lower than its 20-day moving average, and 16.4% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -24.1% The company's stock price performance over the past 12 months beats the peer average by -19.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 72.3% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to email@example.com. © 2020 Kwhen Inc.
Merit Medical: 12% Downside Yet To Be Priced In Amid Flatlining Fundamentals 2022/06/10 16:59:44 Seeking Alpha
Merit Medical looks to have macro-related pressures that are likely headwinds for the company given its softening fundamentals. See more on MMSI stock here.
Steerable Medical Devices Market Is Expected to Witness an Incredible Growth by 2028 with COVID -19 Impact | Merit Medical Systems, Steerable Instruments 2022/05/13 13:23:39 OpenPR
Guidance to several big industries is provided through this Steerable Medical Devices market report to generate huge gains by taking proper actions. It helps industries to accomplish huge growth in the business by covering overall market scenario, visionary ideas, key
Interventional Neurology Devices And Equipment Global Market Report 2022 2022/05/13 10:24:00 GlobeNewswire
Major players in the interventional neurology devices and equipment market are Medtronic, Stryker, Terumo Corporation, Penumbra, Covidien, Abbott, Merit Medical Systems, Johnson & Johnson Services Inc, W. Major players in the interventional neurology devices and equipment market are Medtronic, Stryker, Terumo Corporation, Penumbra, Covidien, Abbott, Merit Medical Systems, Johnson & Johnson Services Inc, W.
Merit Medical Systems, Inc. 2022 Q1 - Results - Earnings Call Presentation (NASDAQ:MMSI) 2022/04/29 17:02:18 Seeking Alpha
The following slide deck was published by Merit Medical Systems, Inc.
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q1 2022 Results - Earnings Call Transcript 2022/04/28 03:07:01 Seeking Alpha
Merit Medical Systems, Inc. (NASDAQ:NASDAQ:MMSI) Q1 2022 Earnings Conference Call April 27, 2022 05:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman and Chief Executive…
Merit Medical Systems Inc. Tops Q1 EPS by 7c By Investing.com 2022/04/27 20:41:01 Investing.com
Merit Medical Systems Inc. Tops Q1 EPS by 7c
Merit Medical Systems Non-GAAP EPS of $0.53 beats by $0.06, revenue of $275.4M beats by $11.08M 2022/04/27 20:22:06 Seeking Alpha
Merit Medical Systems press release (MMSI): Q1 Non-GAAP EPS of $0.53 beats by $0.06.Revenue of $275.4M (+10.6% Y/Y) beats by $11.08M.2022 Financial Guidance"Expects Net revenue in…
Merit Medical Systems COO Ronald Frost to retire 2022/04/21 20:13:55 Seeking Alpha
Merit Medical Systems (MMSI) said Thursday its COO Ronald Frost will retire for personal reasons.MMSI named VP of operations Neil Peterson as COO, effective immediately.
WCM Investment Management LLC Sells 48,557 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) 2021/12/22 12:32:42 Transcript Daily
WCM Investment Management LLC decreased its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 23.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 161,176 shares of the medical instruments suppliers stock after selling 48,557 shares during the quarter. WCM Investment 
Embolotherapy Product Market Demands, Product Type, Size, Revenue and Key Players are Merit Medical, Siemens Healthineers (Varian), Stryker, Jiangsu Hengrui Medicine, Cook Medical 2021/12/20 09:26:49 OpenPR
The Embolotherapy Product Market research report help builds up a clear view of the market trends and development, identify major players in the industry and estimate main downstream sectors. Moreover, the Embolotherapy Product Market research report examines competitive developments such
Emerald Advisers LLC Has $32.30 Million Position in Merit Medical Systems, Inc. (NASDAQ:MMSI) 2021/12/15 18:54:42 Transcript Daily
Emerald Advisers LLC lifted its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 21.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 449,787 shares of the medical instruments suppliers stock after purchasing an additional 80,586 shares during the period. Merit Medical 
Calamos Advisors LLC Makes New $3.41 Million Investment in Merit Medical Systems, Inc. (NASDAQ:MMSI) 2021/12/15 12:12:41 Dakota Financial News
Calamos Advisors LLC purchased a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the 3rd quarter, Holdings Channel reports. The institutional investor purchased 47,532 shares of the medical instruments suppliers stock, valued at approximately $3,413,000. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. 
Global Surgical Blades & Scalpels Market to Grow with a CAGR of 9.31% During 2020-2025; Market to Grow on Account of Increasing Number of Surgical Procedures Worldwide 2021/12/13 13:23:00 Intrado Digital Media
Key Companies Covered in the Global Surgical Blades & Scalpels Market Research Report Are FEATHER Safety Razor Co., Ltd., KAI Group, Aspen Surgical, B. Braun Melsungen AG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Hu-Friedy Mfg. Co., LLC, SteriLance Medical (Suzhou) Inc., Merit Medical Systems, Inc., Shanghai Medical Corporation, Swann-Morton Limited, and other key market players. Key Companies Covered in the Global Surgical Blades & Scalpels Market Research Report Are FEATHER Safety Razor Co., Ltd., KAI Group, Aspen Surgical, B. Braun Melsungen AG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Hu-Friedy Mfg. Co., LLC, SteriLance Medical (Suzhou) Inc., Merit Medical Systems, Inc., Shanghai Medical Corporation, Swann-Morton Limited, and other key market players.